Identification and assessment of bioactive yeast strains and cell wall components

Since yeast probiotics and their cell wall components (CWC) are being used to treat enteric inflammatory diseases in different species including humans, they may be useful for preventing Johne’s disease, a chronic inflammatory bowel disease of ruminants caused by Mycobacterium avium spp. paratuberculosis (MAP). Considerable variation in the efficacy of different yeast probiotics and their […]

Read More
Assessment of safety and efficacy of probiotics use in premature infants

Probiotics are suggested to greatly reduce the risk of mortality and risk of infection in the gut of preterm infants. However, probiotics are rarely given to babies in hospitals in North America. The aim of this study is to assess the effectiveness of probiotics supplementation in improving intestinal heath and preventing gut complications in premature […]

Read More
Characterization of probiotics anti-apoptotic activity

Despite the high prevalence of Inflammatory Bowel diseases (IBD) in industrialized countries, particularly in Canada, the mechanisms controlling these debilitating gastrointestinal pathologies remain poorly understood. IBD is though to arise from an uncontrolled immune response to the intestinal microbiota, inducing a persistent inflammatory reaction in the gut. Death of epithelial cells and loss of epithelial […]

Read More